RT Journal Article
SR Electronic
T1 Capecitabine Plus Bevacizumab for Cardiac Metastasis of Sigmoid Colon Cancer: Case Report and Literature Review
JF In Vivo
JO In Vivo
FD International Institute of Anticancer Research
SP 3413
OP 3419
DO 10.21873/invivo.12180
VO 34
IS 6
A1 SAWAKO HIROI
A1 MASASHI MIGUCHI
A1 SATOSHI IKEDA
A1 HIDEKI NAKAHARA
A1 KATSUNORI SHINOZAKI
A1 TAKASHI NISHISAKA
A1 HIROYUKI EGI
A1 TOSHIYUKI ITAMOTO
YR 2020
UL http://iv.iiarjournals.org/content/34/6/3413.abstract
AB Background/Aim: Right ventricular cardiac metastasis from colorectal cancer (CRC) is rare and clinically silent. There is no standardised treatment. To date, only twelve cases have been reported in the literature. This is a case report and literature review of right ventricular cardiac metastasis from CRC. Case Report: A 75-year-old woman with a history of CRC treated with sigmoidectomy followed by liver and lung metastasectomy presented with a right ventricle tumour. Biopsy showed metastatic adenocarcinoma not suitable for resection because multiple lung metastases coexisted. The metastases were controlled for a prolonged duration by chemotherapy with capecitabine plus bevacizumab. According to the review of 13 cases, the median age of metastatic CRC that involves the right ventricle is 71 years and the primary site is half the colon and rectum. Half of cases have non-cardiac metastases at cardiac metastasis diagnosis. Chemotherapy is more suitable than resection in cases with metastases other than heart because resection of the right ventricle has a high risk. Conclusion: Cardiac right ventricular metastasis from CRC can be controlled by capecitabine plus bevacizumab.